Reported Reactions

Devices › Device types

FDA product code PRC · class 3 · Unknown

Drug-coated peripheral transluminal angioplasty catheter: medical device reports filed with FDA

536 reports carry this product code, 2017–2026; 4 brands with a page.

536
reports with this product code
0% of all MAUDE reports
118
reports, 12 months to August 2026
257 in the 12 months before
19.4%
classified as malfunction
62.3% across all reports
1.5%
classified as death, as reported
0.9% across all reports

Product code PRC is FDA's classification for "Drug-coated peripheral transluminal angioplasty catheter" (unknown panel), a class 3 device. 536 medical device reports carry this product code, 0% of the MAUDE database, from October 2017 to August 2026.

118 reports arrived in the 12 months to August 2026, down 54% from 257 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (79.1%), malfunction (19.4%) and death (1.5%). 4 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
In Pact Av Access293941.2%10%
Lutonix 035AV Drug Coated PTA Dilation Catheter170162.9%19.3%
Lutonix 035 Drug Coated Balloon Pta Catheter1620.4%12.8%
Unspecified Bd Catheter100%78.5%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Medtronic Ireland28853.7%

Reports by month, five years

02549Sep 2021: 1Oct 2021: 1Nov 2021: 1Dec 2021: 12022Jan 2022: 1Feb 2022: 5Mar 2022: 0Apr 2022: 0May 2022: 2Jun 2022: 3Jul 2022: 2Aug 2022: 1Sep 2022: 7Oct 2022: 0Nov 2022: 4Dec 2022: 22023Jan 2023: 3Feb 2023: 1Mar 2023: 1Apr 2023: 2May 2023: 0Jun 2023: 2Jul 2023: 3Aug 2023: 4Sep 2023: 2Oct 2023: 6Nov 2023: 3Dec 2023: 42024Jan 2024: 3Feb 2024: 2Mar 2024: 5Apr 2024: 12May 2024: 5Jun 2024: 3Jul 2024: 4Aug 2024: 6Sep 2024: 5Oct 2024: 7Nov 2024: 10Dec 2024: 32025Jan 2025: 4Feb 2025: 29Mar 2025: 29Apr 2025: 49May 2025: 21Jun 2025: 32Jul 2025: 34Aug 2025: 34Sep 2025: 14Oct 2025: 7Nov 2025: 12Dec 2025: 82026Jan 2026: 11Feb 2026: 6Mar 2026: 16Apr 2026: 9May 2026: 5Jun 2026: 11Jul 2026: 8Aug 2026: 11

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death1.5%8
Injury79.1%424
Malfunction19.4%104
Other0%0
Not given0%0

Who filed

Manufacturer report99.6%534
Voluntary report0.4%2
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Material rupture336.2%
Burst container or vessel264.9%
Difficult to removethe device was hard to remove203.7%
Inflation problem173.2%
Deflation problem132.4%
Leak/splashthe device leaked122.2%
Device-device incompatibility112.1%
Detachment of device or device componentpart of the device came off101.9%
Material separation71.3%
Material deformation50.9%
Material split, cut or torn50.9%
Material twisted/bent50.9%
Retraction problem50.9%
Insufficient device problem information40.7%
Device markings/labelling problema problem with the device markings or label30.6%
Improper or incorrect procedure or method30.6%
Breakthe device broke20.4%
Crackthe device cracked20.4%
Delivered as unsterile product20.4%
Device contamination with chemical or other material20.4%

Questions about drug-coated peripheral transluminal angioplasty catheter reports

What is product code PRC?

FDA's classification code for "Drug-coated peripheral transluminal angioplasty catheter", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.

How many reports carry this code?

536 reports through August 2026, 118 of them in the latest 12 months.

Which brands appear most often?

In Pact Av Access (293), Lutonix 035AV Drug Coated PTA Dilation Catheter (170), Lutonix 035 Drug Coated Balloon Pta Catheter (16) and Unspecified Bd Catheter (1). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.